不同生殖衰老分期及激素替代治疗的绝经期女性性功能障碍状况分析

doi:10.3969/j.issn.1006-7795.2021.04.005

首都医科大学学报 ›› 2021, Vol. 42 ›› Issue (4): 533-539.doi: 10.3969/j.issn.1006-7795.2021.04.005

• 绝经、妇科内分泌与生育力保护 • 上一篇下一篇

不同生殖衰老分期及激素替代治疗的绝经期女性性功能障碍状况分析

鞠蕊¹, 阮祥燕^1*, 代荫梅¹, 白勇涛², 杨幸子², 施琰红², 许新¹, 杨瑜¹, 程姣姣¹, 孙艳华³, 李瑞玲³

1.首都医科大学附属北京妇产医院内分泌科,北京 100026;
2.北京市朝阳区太阳宫社区卫生服务中心妇科,北京 100028;
3.北京市朝阳区妇幼保健院妇科,北京 100022

收稿日期:2021-05-18 出版日期:2021-08-21 发布日期:2021-07-29
基金资助:
北京市医院管理局“登峰”计划专项(DFL20181401),中国健康促进基金会项目(CHPF-2018-OP-11),国家更年期保健特色专科建设单位项目[(2020)30],首批北京市级妇幼保健专科示范单位“更年期保健专科”项目[(2017)35号]。

Study on the situation of female sexual dysfunction in different reproductive aging stages and postmenopausal women using hormone replacement therapy

Ju Rui¹, Ruan Xiangyan^1*, Dai Yinmei¹, Bai Yongtao², Yang Xingzi², Shi Yanhong², Xu Xin¹, Yang Yu¹, Cheng Jiaojiao¹, Sun Yanhua³, Li Ruiling³

1. Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China;
2. Department of Gynecology, Beijing Chaoyang District Taiyanggong Community Health Service Center, Beijing 100028, China;
3. Department of Gynecology, Beijing Chaoyang District Maternal and Child Health Care Hospital, Beijing 100022, China

Received:2021-05-18 Online:2021-08-21 Published:2021-07-29
Contact: * E-mail:ruanxiangyan@ccmu.edu.cn
Supported by:
Beijing Municipal Administration of Hospitals' Ascent Plan(DFL20181401),China Health Promotion Foundation (CHPF-2018-OP-11),National Menopause Health Care Specialist Construction Unit of China [(2020)30], The First Batch of Beijing Maternal and Child Health Specialist Demonstration Units “Menopausal Health Specialist”[(2017) 35].

摘要/Abstract

摘要： 目的调查不同生殖衰老分期女性性功能障碍(female sexual dysfunction,FSD)以及应用激素替代治疗(hormone replace therapy,HRT)的绝经后女性FSD的现状。方法本研究为多中心临床研究,纳入2019年6月至2020年8月在首都医科大学附属北京妇产医院及两家医联体医疗机构就诊且符合纳入和排除标准的女性902例。根据生殖衰老分期(Stages of Reproductive Aging Workshop, STRAW+10)及绝经后女性是否应用激素替代治疗(hormone replace therapy,HRT),将研究对象分为7组:生育期组(reproductive group, R)146例、绝经过渡期早期组(early menopausal transition group, ET)199例,绝经过渡期晚期组(late menopausal transition group, LT)87例,绝经后早期组(early postmenopause group, EP)183例,绝经后晚期组(late postmenopause group, LP)41例,绝经后早期应用HRT组(early postmenopausal women using HRT, EP-HRT)207例应用雌二醇片2 mg/雌二醇地屈孕酮片(2 mg:10 mg),绝经后晚期应用HRT组(late postmenopausal women using HRT, LP-HRT)39例应用雌二醇屈螺酮片(1 mg:2 mg)。女性性功能指数(Female Sexual Function Index, FSFI)量表评估FSD。结果 EP组和LP组的FSD、性欲障碍、阴道润滑障碍、性满意度障碍以及性交痛的比例均明显高于R组、ET组和LT组,LP组性唤起障碍和性高潮障碍的比例、EP组性唤起障碍的比例高于R组、ET组,LT组性欲障碍和性唤起障碍的比例、EP组性高潮障碍的比例高于R组,LP组的阴道润滑障碍和性交痛的比例均高于EP组(P＜0.05)。EP-HRT组的FSD、性欲障碍和性满意度障碍的比例明显低于EP组(P＜0.05)。LP-HRT组的阴道润滑障碍、性满意度障碍以及性交痛的比例明显低于LP组(P＜0.05)。结论女性FSD的比例随生殖衰老分期的提高而显著升高,应用HRT可降低绝经后女性FSD的比例。

关键词: 女性性功能障碍, 女性性功能指数, 生殖衰老分期, 激素替代治疗

Abstract: Objective To investigate the situation of female sexual dysfunction (FSD) at different reproductive stages and the situation of FSD at postmenopausal women using hormone replacement therapy (HRT). Methods A multicenter clinical study was conducted among 902 women in the Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University and other two medical alliance institutions from Jun. 2019 to Aug. 2020. According to the 2011 stages of the Reproductive Ageing Workshop (STRAW+10) and postmenopausal women using HRT or not, the subjects were divided into seven groups: 146 women in reproductive age (R), 199/87 women in early (ET)/late (LT) menopausal transition, 183/41 women in early (EP)/late (LP) postmenopause. Totally 207 women in early postmenopausal stage using estradiol sequentially combined with dydrogesterone (EP-HRT) and 39 women in late postmenopausal stage using estradiol combined with drospirenone administered continuously (LP-HRT). The Female Sexual Function Index (FSFI) was used to assess FSD. Results In group EP and LP, the proportion of FSD, sexual desire disorder, lubrication disorder, dissatisfaction and pain was significantly higher than those in R, ET and LT groups (P＜0.05). In group LP, the proportion of arousal disorder and orgasm disorder was significantly higher than those in R and ET groups (P＜0.05). The proportion of sexual desire disorder, orgasm disorder in LT group, the proportion of orgasm disorder in EP group, and the proportion of arousal disorder in LP group was significantly higher than those in R group. The proportion of lubrication disorder and pain in LP group was significantly higher than those in EP group (P＜0.05). Comparing EP group versus EP-HRT group, the proportion of FSD, sexual desire disorder and dissatisfaction was significantly lower in EP-HRT group (P＜0.05). Comparing LP group versus LP-HRT group, the proportion of FSD, lubrication disorder, dissatisfaction and pain was significantly lower in LP-HRT group (P＜0.05). Conclusion There was a clear association between deteriorating sexual function and increasing STRAW+10 classification, suggesting the consequence of decreasing ovarian function. HRT containing ‘natural hormones' imposed a beneficial effect on FSD.

Key words: female sexual dysfunction, Female Sexual Function Index(FSFI), Stages of Reproductive Aging Workshop(STRAW+10) criteria, hormone replacement therapy

中图分类号:

R711.75

鞠蕊, 阮祥燕, 代荫梅, 白勇涛, 杨幸子, 施琰红, 许新, 杨瑜, 程姣姣, 孙艳华, 李瑞玲. 不同生殖衰老分期及激素替代治疗的绝经期女性性功能障碍状况分析[J]. 首都医科大学学报, 2021, 42(4): 533-539.

Ju Rui, Ruan Xiangyan, Dai Yinmei, Bai Yongtao, Yang Xingzi, Shi Yanhong, Xu Xin, Yang Yu, Cheng Jiaojiao, Sun Yanhua, Li Ruiling. Study on the situation of female sexual dysfunction in different reproductive aging stages and postmenopausal women using hormone replacement therapy[J]. Journal of Capital Medical University, 2021, 42(4): 533-539.

参考文献

[1] Zhang C, Tong J, Zhu L, et al. A population-based epidemiologic study of female sexual dysfunction risk in mainland china: prevalence and predictors[J]. J Sex Med,2017,14(11):1348-1356.
[2] Heidari M, Ghodusi M, Rezaei P, et al. Sexual function and factors affecting menopause: a systematic review[J]. J Menopausal Med,2019,25(1):15.
[3] 鞠蕊,阮祥燕,许新,等. 围绝经期及绝经后女性性功能障碍状况及与更年期症状的关系分析[J]. 首都医科大学学报,2020,41(4):503-507.
[4] 金凤羽,阮祥燕,Mueck Alfred O.,等. 北京及周边地区围绝经期女性性功能现状调查分析[J]. 首都医科大学学报,2017,38(4):509-514.
[5] 阮祥燕,杨欣. 围绝经期异常子宫出血诊断和治疗专家共识[J]. 中华妇产科杂志,2018,53(6):396-401.
[6] Harlow S D, Gass M, Hall J E, et al. Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging[J]. Climacteric,2012,15(2):105-114.
[7] Sun X, Li C, Jin L, et al. Development and validation of Chinese version of female sexual function index in a Chinese population-a pilot study[J]. J Sex Med,2011,8(4):1101-1111.
[8] Simon J A, Davis S R, Althof S E, et al. Sexual well-being after menopause: an international menopause society white paper[J]. Climacteric,2018,21(5):415-427.
[9] Baber R J, Panay N, Fenton A. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy[J]. Climacteric,2016,19(2):109-150.
[10] 陈蓉,林守清. 构建中的生殖衰老分期——生殖衰老分期+10专题研讨会总结摘译[J]. 中国实用妇科与产科杂志,2012,28(9):713-715.
[11] Lou W J, Chen B, Zhu L, et al. Prevalence and factors associated with female sexual dysfunction in Beijing, China[J]. Chin Med J (Engl),2017,130(12):1389-1394.
[12] Tong J, Zhang C, Zhu L, et al. Sexual dysfunction in perimenopausal women based on a national epidemiological survey in China[J]. Climacteric,2019,22(2):190-194.
[13] Zhou Y, Li C, Jin F, et al. Prevalence and predictors of sexual function in midlife partnered Chinese women assessed by two simple indicators: Sexual frequency and sexual desire[J]. J Obstetr Gynaecol Res,2019,45(1):210-216.
[14] Worsley R, Bell R J, Gartoulla P, et al. Prevalence and predictors of low sexual desire, sexually related personal distress, and hypoactive sexual desire dysfunction in a community-based sample of midlife women[J]. J Sex Med,2017,14(5):675-686.
[15] Dąbrowska-Galas M, Dąbrowska J, Michalski B. Sexual dysfunction in menopausal women[J]. Sex Med,2019,7(4):472-479.
[16] 赵婉君,罗晗,韩倩倩,等. 成都市女性性功能障碍的调查与相关因素的探析[J]. 中国性科学,2017,26(6):61-65.
[17] Da S L L, Useche B, Rosa E S J, et al. Sexuality during the climacteric period[J]. Maturitas,2009,62(2):127-133.
[18] Blumel J E, Castelo-Branco C, Binfa L, et al. Quality of life after the menopause: a population study[J]. Maturitas,2000,34(1):17-23.
[19] Thomas H N, Neal-Perry G S, Hess R. Female sexual function at midlife and beyond[J]. Obstetr Gynecol Clin North Am,2018,45(4):709-722.
[20] Wong E L Y, Huang F, Cheung A W L, et al. The impact of menopause on the sexual health of Chinese Cantonese women: A mixed methods study[J]. J Adv Nursing,2018,74(7):1672-1684.
[21] Bell R J, Rizvi F, Islam R M, et al. A systematic review of intravaginal testosterone for the treatment of vulvovaginal atrophy[J]. Menopause,2018,25(6):704-709.
[22] Dennerstein L, Randolph J, Taffe J, et al. Hormones, mood, sexuality, and the menopausal transition[J]. Fertil Steril,2002,77(Suppl 4):S42-S48.
[23] Nijland E A, Weijmar S W, Nathorst-Boos J, et al. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial[J]. J Sex Med,2008,5(3):646-656.
[24] Cappelletti M, Wallen K. Increasing women's sexual desire: the comparative effectiveness of estrogens and androgens[J]. Horm Behav,2016,78:178-193.
[25] American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Gynecology Female sexual dysfunction. ACOG Practice Bulletin Clinical Management Guidelines for obstetrician-gynecologists, number 213[J]. Obstet Gynecol, 2019,134(1):e1-e18.

不同生殖衰老分期及激素替代治疗的绝经期女性性功能障碍状况分析

Study on the situation of female sexual dysfunction in different reproductive aging stages and postmenopausal women using hormone replacement therapy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

本文评价

[1]	鞠蕊, 阮祥燕, 代荫梅, 白勇涛, 杨瑜, 许新, 程姣姣, 杨幸子, 施琰红, 孙艳华, 李瑞玲. 女性性功能障碍的影响因素研究[J]. 首都医科大学学报, 2022, 43(3): 357-363.
[2]	鞠蕊, 阮祥燕, 许新, 杨瑜, 张露平, 秦爽, 王宾红, 豆竹丽, Alfred O. Mueck. 围绝经期及绝经后女性性功能障碍状况及与更年期症状的关系分析[J]. 首都医科大学学报, 2020, 41(4): 503-507.
[3]	杜娟, 阮祥燕, Alfred O. Mueck. 口服避孕药对多囊卵巢综合征患者性功能的影响[J]. 首都医科大学学报, 2018, 39(4): 499-504.
[4]	金凤羽, 阮祥燕, Alfred O. Mueck, 刘玉兰, 杜娟. 北京及周边地区围绝经期女性性功能现状调查分析[J]. 首都医科大学学报, 2017, 38(4): 509-514.
[5]	孙敏玲. 卵巢早衰38例临床分析[J]. 首都医科大学学报, 2009, 30(4): 552-555.